Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.

Front Pharmacol · 2025 · PMC12174393 · PMID 40535773

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Moreover, there was a decreasing trend in NANOG expression compared to the control group ( Figure 8C ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.